Retevmo - Lung and Thyroid Cancers
Lung cancer and thyroid – First RET+ drug, Retevmo
The FDA has approved Retevmo capsules for the treatment of patients with lung cancer or thyroid cancer harboring RET alterations. This is the first therapy approved to target RET gene…